Soluble urokinase-type plasminogen activator receptor is over-expressed in uterine endometrium from women with endometriosis

Molecular Human Reproduction

Volumn 3, Issue 12, 1997, Pages 1101-1105

  Sillem, M ^a   Prifti, S ^a   Monga, B ^a   Buvari, P ^a   Shamia, U ^a   Runnebaum, B ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Endometriosis; Extracellular matrix; In vitro model; Invasion; Plasminogen

Indexed keywords

CELL SURFACE RECEPTOR; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS; UROKINASE;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; ENDOMETRIOSIS; ENDOMETRIUM; ENZYMOLOGY; FEMALE; HUMAN; METABOLISM; PATHOLOGY; SOLUBILITY;

CELLS, CULTURED; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; PLASMINOGEN ACTIVATORS; RECEPTORS, CELL SURFACE; SOLUBILITY; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031298432     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/3.12.1101     Document Type: Article

References (38)

1. Al Roof Higazi, A., Mazar, A., Wang, J. et al (1996) Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1. Blood, 87, 3545-3549.
2. Astedt, B. and Nordenskjöld, F. (1984) Plasminogen activators in endometriosis. Acta Obstet. Gynecol. Scand., 63 (Suppl. 123), 23-24.
3. Bartosik, D., Jacobs, S.L. and Kelly, L.J. (1986) Endometrial tissue in peritoneal fluid. Fertil. Steril., 46, 796-800
4. Batzofin, J.H., Holmes, S.D., Gibbons, W.E. et al. (1985) Peritoneal fluid plasminogen activator activity in endometriosis and pelvic adhesive disease. Fertil. Steril., 44, 277-279.
5. Bianchi, E., Cohen, R.L., Thor, A.T. et al. (1994) The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res., 54, 861-866.
6. Blumenkrantz, M.J., Gallagher, N. and Bahore, R.A. (1981) Retrograde menstruation in women undergoing chronic peritoneal dialysis. Obstet. Gynecol., 57, 667-670.
7. Bouquet de Jolinière, J., Validire, P., Canis, M. et al. (1997) Human endometriosis-derived permanent cell line (FbEM-1): establishment and characterization. Hum. Reprod. Update, 3, 117-123.
8. Casey, J.R., Petranka, J.G., Kottra, J. et al. (1994) The structure of the urokinase-type plasminogen activator receptor gene. Blood, 84, 1151-1156.
9. Casslèn, B., Urano, S., Lecander, I. et al. (1992) Plasminogen activators in the human endometrium, cellular origin and hormonal regulation. Blood Coagul. Fibrinolysis, 3, 133-137.
10. Casslèn, B., Nordengren, J., Gustavsson, B. et al. (1995) Progesterone stimulates degradation of urokinase plasminogen activator (in endometrial stromal cells by increasing its inhibitor and surface expression of the u-PA receptor. J. Clin. Endocrinol. Metab., 80, 2776-2784.
11. Duggan, C., Maguire, T., McDermott, E. et al. (1995) Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J. Cancer, 61, 597-600.
12. Ellis, V., Behrendt, N. and Danø, K. (1991) Plasminogen activation by receptor-bound urokinase. J Biol. Chem., 266, 12752-12758.
13. Evers, J.L.H. (1996) The defense against endometriosis. Fertil. Steril., 66, 351-353
14. Fazleabas, A.T., Khan-Dawood, F.S. and Dawood, M.Y. (1987) Protein, progesterone, and protease inhibitors in uterine and peritoneal fluids of women with endometriosis. Fertil. Steril., 47, 218-224.
15. Fernàndez-Shaw, S., Marshall, J.M., Hicks, B. et al. (1995) Plasminogen activators in ectopic and uterine endometrium. Fertil. Steril., 63, 45-51.
16. Gleeson, N., Gonsalves, R. and Bonnar, J. (1993) Plasminogen activator inhibitors in endometnal adenocarcinoma. Cancer, 72, 1670-1672.
17. Halme, J., Hammond, M.G. and Hulka, J.F. (1984) Retrograde menstruation in healthy women and in patients with endometriosis. Obstet. Gynecol., 64, 141-154.
18. Hulboy, D.L., Rudolph, L.A. and Matrisian, L.M. (1997) Matrix metalloproteinases as mediators of reproductive function. Mol. Hum. Reprod., 3, 27-45.
19. Imai, K., Kanzaki, H. and Mori, T. (1996) Cell surface peptidases in human endometrium. Mol. Hum. Reprod., 2, 425-431.
20. Jenkins, S., Olive, D.L. and Haney, A.F. (1986) Endometriosis: pathogenetic implications of the anatomic distribution. Obstet. Gynecol., 67, 335-338.
21. Kramer, M.D., Schaefer, B. and Reinartz, J. (1995) Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences. Biol. Chem. Hoppe-Seyler, 376, 131-141.
22. Kruitwagen, R.F.P.M., Poels, L.G., Willemsen, W.M.P. et al. (1991) Endometrial epithelial cells in peritoneal fluid during the early follicular phase. Fertil. Steril., 55, 297-303.
23. Leyendecker, G., Kunz, G., Wildt, L. et al. (1996) Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum. Reprod., 11, 1542-1551.
24. Littlefield, B.A. (1991) Plasminogen activators in endometrial physiology and embryo implantation. A review. Ann. N.Y. Acad. Sci., 622, 166-175.
25. Mignatti, P. and Rifkin, D.B. (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev., 73, 161-195.
26. Miyauchi, A., Momoeda, M., Nakabayashi, M. et al (1995) Regulation of the plasminogen activator/plasmin system by epidermal growth factor in cultured endometrial cells. Hum. Reprod., 10, 3284-3288.
27. Mizukami, I.F., Faulkner, N.E., Gyetko, M.R. et al. (1995) Enzyme-linked immunosorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo. Blood, 86, 203-211.
28. Mohanam, S., Sawaya, R., McCutcheon, I. et al. (1993) Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res., 53, 4143-4147.
29. Moll, R., Franke, W.F., Schiller, D.L., et al. (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell, 31, 11-24.
30. Ohtsuka, N. (1980) Study on the pathogenesis of adhesions in endometriosis. Acta Obstet. Gynecol. Jap., 32, 1758-1766.
31. Pyke, C., Eriksen, H., Solberg, B et al. (1993) An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator. FEBS Lett., 326, 69-74.
32. Schatz, F. and Lockwood, C.J. (1993) Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells. J. Clin. Endocrinol. Metab., 77, 621-625.
33. Schatz, F., Aigner, S., Papp, C. et al. (1995) Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1. J. Clin. Endocrinol. Metab., 80, 2504-2510.
34. Sillem, M., Hahn, U., Coddington, C.C. et al. (1996) Ectopic growth of endometrium depends on its structural integrity and proteolytic activity in the cynomolgus monkey (Macaca fascicularis) model of endometnosis. Fertil. Steril., 66, 468-473.
35. Tabibzadeh, S. (1996) The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol. Hum. Reprod., 2, 77-92.
36. Van der Linden P.J.Q., de Goeij A.F.P.M, Dunselman G.A.J. et al. (1996) Endometrial cell adhesion in an in vitro model using intact amniotic membranes. Fertil. Steril., 65, 76-80.
37. Wei, Y., Lukashev, M., Simon, D. et al. (1996) Regulation of integrin function by the urokinase receptor. Science, 273, 1551-1555.
38. Wild, R.A., Zhang, R. and Medders, D. (1994) Whole endometrial fragments form characteristics of in vivo endometriosis in a mesothelial co-culture system: an in vitro model for the study of the histogenesis of endometriosis. J. Soc. Gynecol. Invest., 1, 65-68.